| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/07/2006 | CN1784416A 9-ketospinosyn derivatives |
| 06/07/2006 | CN1784398A 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
| 06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
| 06/07/2006 | CN1784391A Quinazolines useful as modulators of ion channels |
| 06/07/2006 | CN1784387A Benzimidazole derivatives |
| 06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
| 06/07/2006 | CN1783010A Program code size partitioning system and method for multiple memory multi-processing systems |
| 06/07/2006 | CN1781911A Intermediate for producing novel pyrazine derivatives |
| 06/07/2006 | CN1258531C Aminomethyl pyrrolidine derivatives having aromatic substituents |
| 06/07/2006 | CN1258529C Process for preparing diaryl-4-amino-piperidinyl compounds |
| 06/06/2006 | US7057051 Substituted imidazoles as cannabinoid receptor modulators |
| 06/06/2006 | US7057048 Androgen receptor antagonists |
| 06/06/2006 | US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8) |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056935 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 06/06/2006 | US7056927 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | US7056923 Anticoagulants |
| 06/06/2006 | US7056921 Substituted chroman derivatives |
| 06/06/2006 | US7056918 Benzimidazole anti-inflammatory compounds |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056914 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056894 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof |
| 06/06/2006 | US7056354 produces powerful, particularly bright and chromatic color, particularly red shades that are free of or contain very little blue or yellow; resistance to light, bad weather, washing, permanent-waving, perspiration and friction |
| 06/06/2006 | US7056348 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair) |
| 06/06/2006 | CA2166800C 4-substituted piperidine derivatives useful as neurokinin antagonists |
| 06/06/2006 | CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives |
| 06/06/2006 | CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006057323A1 Composition for amyloid-associated disease diagnosis |
| 06/01/2006 | WO2006056884A1 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors |
| 06/01/2006 | WO2006056850A2 Chroman compounds |
| 06/01/2006 | WO2006056845A1 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
| 06/01/2006 | WO2006056815A1 Indole-2-carboxylic acid amides |
| 06/01/2006 | WO2006028957A8 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 06/01/2006 | WO2005061467A3 Piperazine derivatives as bradykinin antagonists |
| 06/01/2006 | WO2005034940A8 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 06/01/2006 | US20060116420 Crystalline forms of 3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxycarbonyl-paclitaxel |
| 06/01/2006 | US20060116411 Medicinal composition containing triazole compound |
| 06/01/2006 | US20060116399 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 06/01/2006 | US20060116396 5-Substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 06/01/2006 | US20060116390 Hepatitis c virus inhibitors |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | CA2589258A1 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors |
| 06/01/2006 | CA2587888A1 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/01/2006 | CA2587860A1 Chroman compounds |
| 06/01/2006 | CA2586972A1 Cycloalkyl piperidine tachykinin receptor antagonists |
| 05/31/2006 | EP1661881A2 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660487A1 Pyrrole compositions useful as inhibitors of c-met |
| 05/31/2006 | EP1660486A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 05/31/2006 | EP1660473A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 05/31/2006 | EP1660458A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 05/31/2006 | EP1660455A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/31/2006 | EP1660453A2 Process for the preparation of 4-amino-3-quinolinecarbonitriles |
| 05/31/2006 | EP1660452A1 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 05/31/2006 | EP1660448A1 Indol-2-amides as glycogen phosphorylase inhibitors |
| 05/31/2006 | EP1660447A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660092A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 05/31/2006 | EP1556356B1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 05/31/2006 | EP1453512B1 Acetylene derivatives having mglur 5 antagonistic activity |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP1072598B1 Pyrazolinone derivatives |
| 05/31/2006 | CN1780822A Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (MPO) |
| 05/31/2006 | CN1780621A Sulfonamide derivatives as gamma secretase inhibitors. |
| 05/31/2006 | CN1780617A Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 05/31/2006 | CN1778797A Production of N-(pyrrolo[2,3-d] pyrimidine-5-) acyl glusate derivative and intermediate |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/30/2006 | US7053223 Inhibitors of farnesyl protein transferase |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053107 Antiproliferative agents, angiogenesis inhibitors for treating cancer, eye disorders, diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis; N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide |
| 05/30/2006 | US7053105 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 05/30/2006 | US7053100 A cis isomer of 1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-5-fluorocytosine has potent activity against hepatitis B virus infection; administration by rectal, nasal, topical, transdermal, vaginal, parenteral, intravenous injection |
| 05/30/2006 | US7053095 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053078 Serine protease inhibitors |
| 05/30/2006 | US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/30/2006 | CA2398159C Sulphonylaminocarbonyltriazolinones having substitutents bonded via oxygen |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/30/2006 | CA2157668C Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation |
| 05/30/2006 | CA2141692C Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
| 05/26/2006 | WO2006055760A1 Triazole compounds that modulate hsp90 activity |
| 05/26/2006 | WO2006055725A2 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | WO2006055463A2 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |